Welcome to our dedicated page for Aflac news (Ticker: AFL), a resource for investors and traders seeking the latest updates and insights on Aflac stock.
Aflac Incorporated (NYSE: AFL) is a Fortune 500 insurer in the direct life and supplemental health insurance space, with major operations in the United States and Japan. The AFL news feed on Stock Titan brings together company-issued updates and market-moving announcements that reflect how Aflac manages its insurance business, capital, partnerships and community initiatives.
Recent Aflac news has covered a range of topics, including quarterly and annual earnings releases, dividend declarations and conference call schedules where management discusses financial results. These items provide insight into segment performance for Aflac U.S. and Aflac Japan, trends in net earned premiums and adjusted earnings, and the company’s approach to capital deployment through dividends and share repurchases.
News stories also highlight Aflac’s strategic partnerships and product-related initiatives. Examples include collaborations to integrate Aflac’s supplemental health products with benefits technology platforms and administrative partners, particularly in the public sector market and employer benefits space. Such announcements illustrate how Aflac connects its supplemental health offerings with employer-sponsored benefits and consumer-directed health care administration.
Aflac’s communications frequently emphasize its role in workplace benefits trends through the Aflac WorkForces Report, which examines employee stress, burnout, financial fragility and the perceived value of supplemental insurance. Other articles focus on the company’s philanthropic efforts, such as support for the Aflac Childhood Cancer Foundation, the My Special Aflac Duck® program and the “Beyond Words” children’s book, all aimed at assisting children and families facing cancer and blood disorders.
Investors and observers following AFL news can use this page to monitor earnings announcements, dividend decisions, risk disclosures, benefits-related research and community initiatives that shape Aflac’s profile as a supplemental health and life insurer. Bookmark this feed to review new press releases and regulatory-related communications as they are issued by the company.
Aflac Incorporated (NYSE: AFL) announced a 17.9% increase in its first quarter dividend to $0.33 per share, payable on March 1, 2021. Shareholders of record at the close of business on February 17, 2021 will receive this dividend. CEO Daniel P. Amos emphasized the company’s commitment to maintaining strong capital ratios while rewarding shareholders and continuing its long-standing record of 38 consecutive years of dividend increases.
Aflac Incorporated (NYSE: AFL) will host its annual Financial Analysts Briefing on November 19, 2020, from 8:00 a.m. to 11:00 a.m. (ET). The event will cover Aflac's business operations in Japan and the United States, focusing on financial outlook and capital management strategies amid the COVID-19 pandemic. Interested participants need to register here. Presentation slides will be posted on investors.aflac.com after market close on November 18, 2020.
Aflac Incorporated (NYSE: AFL) has completed the acquisition of Zurich North America's U.S. Corporate Life and Pensions business, including the Benefit Harbor Insurance Services. This acquisition aligns with Aflac's buy-to-build strategy, promoting capital deployment into growth initiatives. The total transaction value is below $200 million, with expected annualized premium from in-force group life and disability policies at approximately $120 million. Aflac anticipates modest run-rate dilution in the near term, enhancing its value proposition and market opportunities.
Aflac recognized its top-12 employee volunteers for 2019, who logged over 16,450 hours of service to various charities. This marks a 7% increase in volunteer hours compared to 2018. Aflac has a long-standing tradition of community service, with 461 employees participating, a 2% rise from the previous year. Honorees will receive a customized sign in their yards and a donation to their chosen charity. Aflac emphasizes its commitment to corporate social responsibility, recently earning accolades as a 2020 goBeyondProfit Champion for its community engagement.
Aflac reported significant growth in its third quarter 2020 results, with total revenues rising to $5.7 billion, up from $5.5 billion in Q3 2019. Net earnings surged to $2.5 billion or $3.44 per diluted share, boosted by a $1.4 billion tax benefit. Adjusted earnings also increased 15.2% to $994 million. However, premium income in Japan and the U.S. declined 2.3% and 2.6%, respectively, due to COVID-19 impacts. The board declared a fourth-quarter dividend of $0.28 per share.
Aflac Incorporated (NYSE: AFL) is set to release its third quarter financial results on October 27, 2020, after market closure. Earnings materials will be accessible on the company's Investor Relations website. A conference call to discuss the results, featuring key executives including Chairman and CEO Daniel P. Amos, is scheduled for 9:00 a.m. (ET) on October 28, 2020. The discussion will cover the financial outlook amidst the ongoing COVID-19 pandemic.
Summary not available.
Aflac has released its 2019 Corporate Social Responsibility Report, celebrating 65 years of commitment to ethical business practices. The report highlights Aflac's initiatives in governance, workplace inclusivity, philanthropy, and environmental sustainability. Key achievements include a 64% representation of ethnic minorities and women on its board, a contribution of over $172 million to pediatric cancer support, and a 48% reduction in carbon emissions in Japan since 2004. Aflac aims to create a better future for its stakeholders while upholding its core values.
Aflac announced a $1.5 million annual contribution to the Sickle Cell Disease Program at the Aflac Cancer and Blood Disorders Center in Atlanta, marking a total of over $6 million donated. This initiative coincides with National Sickle Cell Awareness Month and highlights Aflac's commitment to combating this inherited disease that impacts children significantly. In 2019, over 2,050 children were treated for sickle cell disease at the center. Aflac's funding aims to enhance treatment capabilities, especially through bone marrow transplants, aligning with their environmental, social, and governance (ESG) initiatives.
Summary not available.